| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2007.
IN THIS ISSUE
| The first 10% of the full text of this article appears below. |
Colony-Stimulating Factors, Breast Cancer, and Leukemia Risk
Granulocyte and granulocytemacrophage colony-stimulating factors (G-CSF), which stimulate hematopoiesis (blood cell production), are used increasingly in women with breast cancer to enable them to endure higher chemotherapy doses than would otherwise be possible. Data from in vitro and epidemiologic studies, however, have suggested that these cytokines may increase the risk of acute myelocytic leukemia (AML) and myelodysplastic syndrome (MDS). Hershman et al. (p. 196) analyzed these outcomes in women in a Surveillance, Epidemiology, and End Results (SEER)Medicare database who received chemotherapy for breast cancer. Women who had received concurrent growth
Myocardial Infarction Mortality Risk After Hodgkin Disease
The Risk of Second Cancers in Patients with Hairy Cell Leukemia
FGF-2, SDF-1, and Hematopoiesis in Myeloid Disorders
Quality of Reporting in Cancer Prognostic Marker Study Design
Identification of DNA Mismatch RepairDeficient Colorectal Cancer
Related Articles in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2007 99: 183-186.
J Natl Cancer Inst 2007 99: 186-187.
J Natl Cancer Inst 2007 99: 196-205.
J Natl Cancer Inst 2007 99: 206-214.
J Natl Cancer Inst 2007 99: 215-222.
J Natl Cancer Inst 2007 99: 223-235.
J Natl Cancer Inst 2007 99: 236-243.
J Natl Cancer Inst 2007 99: 244-252.